Dae Young Hur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dae Young Hur has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Daeho Cho
Kine Sciences, 525, Seolleung-ro, Gangnam-gu, Seoul 06149, Korea
1 shared publication - Daejin Kim
Department of Anatomy, Inje University College of Medicine, Busan 614-735, Korea
1 shared publication - Hyun Jeong Park
Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
1 shared publication - Kyung Eun Kim
Department of Health Industry Sookmyung Women's University Seoul Republic of Korea
1 shared publication - Sa Ik Bang
Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
1 shared publication - Seonghan Kim
Department of Anatomy, College of Medicine, Inje University, Busan 47392, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 24 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (7) , 1600
The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
Artemisinin, a chemical compound used for the treatment of malaria, has been known to show anti-cancer activity. However, the effect of this chemical on natural killer (NK) cells, which are involved in tumor killing, remains unknown. Here, we demonstrate that artemisinin exerts a potent anti-cancer effect by activating NK cells. NK-92MI cells pre-treated with artemisinin were subjected to a cytotoxicity assay using K562 cells. The results showed that artemisinin significantly enhances the cytolytic activity of NK cells in a dose-dependent manner. Additionally, the artemisinin-enhanced cytotoxic effect of NK-92MI cells on tumor cells was accompanied by the stimulation of granule exocytosis, as evidenced by the detection of CD107a expression in NK cells. Moreover, this enhancement of cytotoxicity by artemisinin was also observed in human primary NK cells from peripheral blood. Our results suggest that artemisinin enhances human NK cell cytotoxicity and degranulation. This is the first evidence that artemisinin exerts antitumor activity by enhancing NK cytotoxicity. Therefore, these results provide a deeper understanding of the action of artemisinin and will contribute to the development and application of this class of compounds in cancer treatment strategies.
- 24 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (7) , 1600
Open AccessThe Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
Artemisinin, a chemical compound used for the treatment of malaria, has been known to show anti-cancer activity. However, the effect of this chemical on natural killer (NK) cells, which are involved in tumor killing, remains unknown. Here, we demonstrate that artemisinin exerts a potent anti-cancer effect by activating NK cells. NK-92MI cells pre-treated with artemisinin were subjected to a cytotoxicity assay using K562 cells. The results showed that artemisinin significantly enhances the cytolytic activity of NK cells in a dose-dependent manner. Additionally, the artemisinin-enhanced cytotoxic effect of NK-92MI cells on tumor cells was accompanied by the stimulation of granule exocytosis, as evidenced by the detection of CD107a expression in NK cells. Moreover, this enhancement of cytotoxicity by artemisinin was also observed in human primary NK cells from peripheral blood. Our results suggest that artemisinin enhances human NK cell cytotoxicity and degranulation. This is the first evidence that artemisinin exerts antitumor activity by enhancing NK cytotoxicity. Therefore, these results provide a deeper understanding of the action of artemisinin and will contribute to the development and application of this class of compounds in cancer treatment strategies.